Automated weekly reports tracking competitor pipelines, FDA filings, clinical trials, funding, and deals. Built for biotech founders who can't justify $30k/year for Citeline.
From $199/month — cancel anytime
Data sourced from
We track the signals that matter for your pipeline — so your team doesn't have to.
New trials filed, phase transitions, completion and failure events across your competitive set.
INDs, NDAs, BLAs, 510(k) clearances, orphan drug designations — tracked in real time.
New funding rounds, partnership announcements, licensing deals, and M&A activity.
New peer-reviewed publications from competitor research teams, tracked via PubMed.
Leadership changes at competitor companies that signal strategic shifts.
Clean PDF report + email digest, every Monday. Optional Slack integration.
The enterprise tools cost $30k–$100k/year and were built for teams of analysts. PipelineRadar delivers the same data, directly to your inbox.
| Feature | PipelineRadar | Citeline / Evaluate | Manual (Google Alerts) |
|---|---|---|---|
| FDA & clinical trial tracking | ✓ Automated | ✓ Automated | ✗ Missed signals |
| Funding & deal monitoring | ✓ Weekly | ✓ Real-time | ✗ Inconsistent |
| Custom competitor set | ✓ Fully custom | ✓ | ✗ |
| Setup time | Under 10 minutes | Weeks (enterprise onboarding) | Ongoing manual work |
| Monthly cost | From $199 | $2,500–$8,000+ | $0 (but hours of analyst time) |
No annual contracts. No enterprise sales calls. Cancel any time.
For early-stage teams monitoring one therapeutic area.
For growing biotechs watching multiple programs.
For established programs needing full coverage.
Tell us your therapeutic area and we'll build a competitive intelligence report for your pipeline — no commitment required.
We'll follow up within 24 hours. No spam, ever.